Montana Hematology Oncology Conference
The Montana Hematology Oncology Conference is a 1-day educational and scientific meeting that will focus on key clinical topics in the management of common malignancies. This conference will feature leading experts discussing the latest diagnostic, therapeutic, and supportive care strategies in cancer management. The field of oncology is continually evolving with the introduction of new targeted therapies, cellular therapies, and immunotherapy. These advances present new opportunities to tailor treatment approaches for cancer patients based on disease-related and patient-related factors. Significant disparities exist in access to continuing education for physicians practicing in rural settings. Engaging, easily accessible continuing education activities focusing on content that has practical applications for the provider may significantly impact patient outcomes. There is a need for these educational activities in rural settings to update practicing healthcare providers about recent advances in the field. This highly practical and interactive symposium will provide a unique opportunity for healthcare professionals to learn from and interact with well-known experts in the field.
Target Audience
- Hematologist/Oncologists
- Oncology Physician Assistants/Nurse Practitioners
- Oncology Pharmacists
- Oncology Nurses
ORGANIZING COMMITTEE
Course Director:
Binay Shah, MD, MHA - Binaytara Foundation
Conference Chair
Srinivas Tantravahi, MBBS, MRCP - University of Utah Huntsman Cancer Institute
VENUE INFORMATION
If you are attending this meeting and need to reserve a hotel room, please reserve your room at the link below to take advantage of the discounted group rate of $289 per night plus applicable taxes and fees. The cut off date is May 7th, 2024:
Booking link: https://lodgeatwhitefishlake.com/groupslogin
Group ID: Binay24
Group Password: WHITEFISH
Learning Objectives
- Review pertinent clinical trial data for the standard of care and novel management strategies for common malignancies.
- Discuss the study design and primary endpoints of recently reported and ongoing trials that have influenced the changes in the standards of care for cancer patients.
- Individualize management of cancer patients based on emerging data from clinical trials and evolving expert guidelines.
- Compare and contrast the safety and efficacy profiles of novel therapeutic strategies that impact the management of common malignancies.
GLOBAL ONCOLOGY PROJECT
Click this link to learn more about our ongoing project building a 200-bed cancer hospital in Nepal: https://binayfoundation.org/cancer-hospital/
June 8, 2024
All times are listed in Mountain Standard Time (MST).
07:00 AM – 08:00 AM Registration, Breakfast, & Exhibits
08:00 AM – 08:05 AM Welcome Remarks
08:05 AM – 08:20 AM Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA
08:20 AM – 09:50 AM Session 1: Women’s Cancers
Moderator: Elizabeth Bigger, MD
08:20 AM – 08:50 AM Non-Metastatic Breast Cancer - Recent Advances - Christos Vaklavas, MD
08:50 AM – 09:20 AM Management of Metastatic Breast Cancer in 2024 - Stephen Kimani, MD, MSc
09:20 AM – 09:50 AM Advances in Management of Ovarian Cancer - Elise J. Simons, MD, FACOG
09:50 AM – 10:00 AM Break & Exhibits
10:00 AM – 12:00 PM Session 2: General Oncology
Moderator: Jack Hensold MD
10:00 AM – 10:30 AM Biomarker-Guided Treatment of Advanced Non-Small Cell Lung Cancer - Lei Deng, MD
10:30 AM – 11:00 AM Advances in the Management of Advanced Prostate Cancer - Umang Swami, MD
11:00 AM – 11:30 AM Management of Immunotherapy Toxicities - Kara Schenk, MD
11:30 AM – 12:00 PM Panel Discussion
12:00 PM – 01:00 PM Lunch & Exhibits
01:00 PM – 02:30 PM Session 3: GI Oncology
Moderator: Justin D Thomas, MD
01:00 PM – 01:30 PM Advances in the Management of Colorectal Cancer - Ronan Hsieh, MD
01:30 PM – 02:00 PM Updates in the Management of Gastric and GE junction Cancers - Shiven Patel, MD, FACP
02:00 PM – 02:30 PM Panel Discussion
02:30 PM – 03:00 PM Break & Exhibits
03:00 PM – 04:00 PM Session 4: Hematologic Malignancies
Moderator: Srinivas Tantravahi, MBBS, MRCP
03:00 PM – 03:30 PM Recent Updates in Management of Diffuse Large B cell Lymphoma - Lindsey Fitzgerald, MD
03:30 PM – 04:00 PM Updates in the Management of Multiple Myeloma - Douglas Sborov, MD, MS
04:00 PM – 04:05 PM Adjourn
If you are attending this meeting and need to reserve a hotel room, please reserve your room at the link below to take advantage of the discounted group rate of $289 per night plus applicable taxes and fees. The cut off date is May 7th, 2024:
Booking link: https://lodgeatwhitefishlake.com/groupslogin
Group ID: Binay24
Group Password: WHITEFISH
IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:
All conflict of interest has been identified and mitigated for individuals in control of contents.
PLANNING COMMITTEE DISCLOSURE STATEMENT:
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
Binay Shah, MD, MHA
Srinivas Tantravahi, MBBS; MRCP
Lei Deng, MD
Lindsey Fitzgerald, MD
Ronan Hsieh, MD, MS
Stephen Kimani, MD, MSc
Shiven Patel, MD, MBA, FACP
Douglas Sborov, MD MS
Kara Schenk, MD
Elise Simons, Clinical Assistant Professor, Division of Gynecologic Oncology, University of Washington
Umang Swami, MD, MS
Christos Vaklavas, M.D., Associate Professor
Elizabeth Bigger
Jack Hensold, MD
Justin Thomas
Acknowledgment of Commercial Support
This activity is supported with an independent Medical Education Grant from AstraZeneca.
Available Credit
- 6.00 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 6.00 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 6.00 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.
If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information
Price
POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE:
All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place.
The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference. The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees.
If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.
Violating this policy will result in a fine equivalent to a general display fee for that conference.
If your company has purchased an exhibit or sponsorship, please register at the link below to receive the discounted registration fees:
Link to register as an additional rep of a sponsoring company: https://education.
NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
- If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
CANCELLATION POLICY
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
- No refunds will be issued if registration is canceled after that date.
No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.